Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

First, let’s take a look at the private biotech investments in May 2025, breaking them down by value, location, funding type, and therapeutic subsector. In May 2025, it was Pathos AI that secured the ...

In April, the major pharma giants in the mergers and acquisitions (M&As) space were Novartis and Merck. Last month, however, the big names that announced multimillion-dollar buyouts were GSK, Sanofi, ...